Status:
COMPLETED
Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Healthy Subjects
Eligibility:
All Genders
20-60 years
Phase:
PHASE3
Brief Summary
Benfotiamine pretreatment (3 days)at high dosage (1050 mg/day) prevents in healthy subjects smoking-induced vascular dysfunction assessed by ultrasound flow mediated dilatation of the brachial artery.
Detailed Description
Benfotiamine pretreatment (3 days)at high dosage (1050 mg/day) prevents in healthy subjects smoking-induced vascular dysfunction assessed by ultrasound flow mediated dilatation (FMD) of the brachial a...
Eligibility Criteria
Inclusion
- healthy habitual smokers
Exclusion
- any kind of chronic disease
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00785460
Start Date
January 1 2008
Last Update
November 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart and Diabetes Center
Bad Oeynhausen, North Rhine-Westphalia, Germany, 32545